TrialAsia-Pacific journal of clinical oncology2022

Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Yukio Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.